LIMITED.webp)
Edg Pharmaceuticals (India) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-10-2024
- Paid Up Capital ₹ 3.70 M
as on 23-10-2024
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 7.50 M
as on 23-10-2024
- Revenue 5.10%
(FY 2023)
- Profit 74.72%
(FY 2023)
- Ebitda 35.32%
(FY 2023)
- Net Worth 190.55%
(FY 2023)
- Total Assets 26.23%
(FY 2023)
About Edg Pharmaceuticals (India)
The Corporate was formerly known as Edg Pharmaceuticals (India)Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.70 M.
The company currently has active open charges totaling ₹7.50 M.
Palanisami Thavamanidevi, Deivasigamani Palaniswamy, and Nallagounder Arun serve as directors at the Company.
- CIN/LLPIN
U24231TZ2011PTC017367
- Company No.
017367
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Aug 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Edg Pharmaceuticals (India) Private Limited offer?
Edg Pharmaceuticals (India) Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Pain Relief Spray.
Who are the key members and board of directors at Edg Pharmaceuticals (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Palanisami Thavamanidevi  | Director | 29-Aug-2011 | Current |
| Deivasigamani Palaniswamy | Director | 29-Aug-2011 | Current |
Nallagounder Arun  | Director | 29-Aug-2011 | Current |
Financial Performance of Edg Pharmaceuticals (India).
Edg Pharmaceuticals (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 5.1% increase. The company also saw a substantial improvement in profitability, with a 74.72% increase in profit. The company's net worth Soared by an impressive increase of 190.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Edg Pharmaceuticals (India)?
In 2023, Edg Pharmaceuticals (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Purani Hospital Supplies Private LimitedActive 24 years 8 monthsPalanisami Thavamanidevi, Deivasigamani Palaniswamy and 1 more are mutual person
Aosta India Private LimitedActive 24 years 10 monthsPalanisami Thavamanidevi and Nallagounder Arun are mutual person
Kovai Medical Center And Hospital LimitedActive 39 years 4 monthsPalanisami Thavamanidevi and Nallagounder Arun are mutual person
Kovai Purani Finance Private LimitedActive 34 years 2 monthsPalanisami Thavamanidevi and Nallagounder Arun are mutual person
- Pavai Property Developers Private LimitedActive 30 years 1 month
Palanisami Thavamanidevi is a mutual person
- M A P S Travels Private LimitedActive 29 years 2 months
Deivasigamani Palaniswamy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
City Union Bank Limited Creation Date: 04 Jul 2012 | ₹7.50 M | Open |
How Many Employees Work at Edg Pharmaceuticals (India)?
Unlock and access historical data on people associated with Edg Pharmaceuticals (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Edg Pharmaceuticals (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edg Pharmaceuticals (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
